A primary difficulty in developing therapeutics for brain disorders is that the underlying etiological mechanisms are not well understood. We have made recent breakthroughs in our understanding of the relationship between electrical activity in the brain and behavior, which is promising for shedding light on these mechanisms. My lab studies networks of electrical activity in the brain using pre-clinical rodent models of disease and is working to identify the cellular and molecular factors that contribute to the organization of such networks. Our overarching goal is to promote the development of precision medicine (i.e. therapeutics targeted to specific individuals) by identifying therapeutic targets that promote healthy brain electrical network activity.